e-learning
resources
Vienna 2009
Tuesday, 15.09.2009
Pulmonary circulation II
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Chronic hypoxia-induced pulmonary hypertension is linked to a decrease in the soluble epoxide hydrolase
B. Keserü, B. Fisslthaler, N. Weissmann, I. Fleming (Frankfurt am Main, Giessen, Germany)
Source:
Annual Congress 2009 - Pulmonary circulation II
Session:
Pulmonary circulation II
Session type:
Thematic Poster Session
Number:
3937
Disease area:
Pulmonary vascular diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
B. Keserü, B. Fisslthaler, N. Weissmann, I. Fleming (Frankfurt am Main, Giessen, Germany). Chronic hypoxia-induced pulmonary hypertension is linked to a decrease in the soluble epoxide hydrolase. Eur Respir J 2009; 34: Suppl. 53, 3937
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
The definition of pulmonary hypertension: history, practical implications and current controversies
Should we screen for hereditary pulmonary hypertension?
Patient with ankylosing spondylitis and pulmonary hypertension
Related content which might interest you:
Functional upregulation of PRMT2 in chronic hypoxia-induced pulmonary hypertension
Source: Eur Respir J 2004; 24: Suppl. 48, 721s
Year: 2004
Localisation of NADPH oxidases and their role in hypoxia induced pulmonary hypertension
Source: Eur Respir J 2006; 28: Suppl. 50, 804s
Year: 2006
Increased xanthine oxidase activity in idiopathic pulmonary arterial hypertension
Source: Eur Respir J 2009; 34: 276
Year: 2009
Targeting of mitochondrial superoxide in chronic hypoxia-induced pulmonary hypertension
Source: International Congress 2019 – Pulmonary hypertension with lung diseases and experimental pulmonary hypertension
Year: 2019
Early atorvastatin administration suppresses the oxygen-activating ability of rat neutrophils during monocrotalinin-induced pulmonary arterial hypertension (PAH).
Source: Virtual Congress 2020 – Experimental approaches to pulmonary hypertension
Year: 2020
A novel piperidine attenuates pulmonary arterial hypertension via regulating BMP2 and PTGS2 levels
Source: International Congress 2018 – Pathobiology of pulmonary hypertension
Year: 2018
Dependence of stage of severity of chronic obstructive pulmonary disease on metalloproteinase 1, 12, surfactant protein C, microsomal epoxid hydrolase gene polymorphisms
Source: Eur Respir J 2006; 28: Suppl. 50, 523s
Year: 2006
Genetic polymorphism of epoxide hydrolase and glutathione S-transferase in COPD
Source: Eur Respir J 2004; 23: 818-824
Year: 2004
Effects of the NO donor molsidomine on prostacyclin synthase gene expression in rats with chronic hypoxic pulmonary hypertension
Source: Eur Respir J 2001; 18: Suppl. 33, 414s
Year: 2001
Improvement of exercise capacity in monocrotaline induced pulmonary hypertension by the phosphodiesterase inhibitor Vardenafil
Source: Annual Congress 2006 - Signalisation in the pulmonary vasculature: new pathways and wrong signals
Year: 2006
Genetic variants of microsomal epoxide hydrolase and glutamate-cysteine ligase in COPD
Source: Eur Respir J 2008; 32: 931-937
Year: 2008
ACE2 activation improves pulmonary endothelial function and attenuates monocrotaline-induced pulmonary hypertension
Source: Annual Congress 2011 - Treatment of human pulmonary hypertension
Year: 2011
Attenuated expression and activity of dimethylarginine dimethylaminohydrolase may play a key role in monocrotaline-induced pulmonary hypertension by accumulation of endogenous NOS inhibitors in rats
Source: Annual Congress 2006 - Signalisation in the pulmonary vasculature: new pathways and wrong signals
Year: 2006
Prevention and partial reversal of monocrotaline-induced pulmonary arterial hypertension (PAH) by hsp90 inhibitors
Source: Annual Congress 2012 - Pulmonary circulation: basic mechanisms, animal models and experimental treatments
Year: 2012
Oestradiol ameliorates monocrotaline pulmonary hypertension via NO, prostacyclin and endothelin-1 pathways
Source: Eur Respir J 2013; 41: 1116-1125
Year: 2013
Increased rho-kinase activity is related to pulmonary endothelial dysfunction in patients with chronic obstructive pulmonary disease (COPD)
Source: Annual Congress 2008 - Pulmonary vascular biology
Year: 2008
Elevated levels of adenosine in the lungs lead to chronic lung injury and pulmonary hypertension
Source: Annual Congress 2011 - Experimental pulmonary hypertension
Year: 2011
Copper restriction prevents and reverses angioproliferation in experimentally induced pulmonary arterial hypertension (PAH)
Source: Annual Congress 2009 - Pathobiology of pulmonary hypertension
Year: 2009
Riociguat: an upcoming therapy in chronic thromboembolic pulmonary hypertension?
Source: Eur Respir Rev 2009; 19: 68-71
Year: 2010
Right heart hypertrophy in mice deficient of the mitochondrial regulator protein p66shc is decreased after chronic hypoxic exposure by a cyclophilin D dependent mechanism
Source: International Congress 2014 – Pulmonary hypertension: right ventricle and basic physiology
Year: 2014
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept